DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02566 JIUYUAN GENE

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Hu Kaijun & Associates (17.16%)
Hangzhou Huasheng Pharmaceutical Group Co., Ltd. (13.24%)
Corporacion Quimico-farmaceutica Esteve, Sociedad Anonima (12.22%)
Insigma Technology Co., Ltd. (9.99%)
Yang Loon Chun (8.15%)
Hangzhou Investment Holdings Co., Ltd. (7.10%)
Hangzhou Heda Jinyuan Equity Investment Fund Partnership Enterprise (Limited Partnership) (5.05%)		 Sector Health Care & Biotechnology
Web Site https://www.china-gene.com Tel (86 571) 8691-0099
Email office@china-gene.com Fax (86 571) 8691-1688
Related Equities N/A
Principal Activities Principally engaged in the research and development, manufacturing and commercialisation of biopharmaceutical products.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top